Events

Upcoming events in English:

 

 

• • • • •
Zoom webinar Sept 25th 2021. David E. Nichols: Overview of Medicinal Chemistry Research on Psychedelics - When psychedelics were criminalized at the turn of the 1970s, most research on them also came to a halt. Yet, some avenues of study still remained open. Veteran of psychedelic research, pharmacologist and chemist David E. Nichols, PhD, has been researching psychedelics since 1969 – over the course of seven decades. On Saturday, September 25th,… Read more
Zoom webinar Aug 30th 2021. MDMA therapy for the treatment of trauma: A clinical trial therapist’s perspective - MDMA-assisted psychotherapy has received a lot of attention in the treatment of post-traumatic stress disorder (PTSD), but what exactly happens in an MDMA therapy session? Why is working with PTSD challenging, and how might MDMA help? What is the “inner-directed” approach utilized in clinical trials of MDMA-assisted therapy? On Monday, August 30th 6PM UTC+3, the… Read more
Conference: Psykedeelit 2021 - Psykedeelit 2021 November 18–19, 2021 Conference for Psychedelic Research Axelia, Auditorium Salin, Piispankatu 8, Turku Psychedelic research has experienced a renaissance, and studies which have been neglected for years have been revived in universities across the world. Therapeutic potential of psychedelic substances for the treatment of various mental health problems is being investigated widely. Scholarly… Read more
Psychedelic-assisted psychotherapies – an overview of current research – Webinar on May 18th (in Finnish) - The therapeutic potential of psychedelics is receiving increased attention. What exactly are psychedelics and psychedelic therapy? What is the state of the current research on them? Our webinar on May 18th offers a general overview of the topic. The event is in Finnish. Read more
Taking a look at the methodological challenges in psychedelic research – Webinar on April 23th (in Finnish) - Research on the therapeutic effects of psychedelics has yielded promising results. Yet, research on psilocybin and other classical psychedelics has been conducted with relatively small patient populations. In addition to larger sample sizes, future studies will also benefit from discussions regarding the methodological problems, challenges and limitations of research conducted so far. Our webinar on… Read more
Ketamine in Psychiatry – online seminar - Classic psychedelics may be making their way into psychiatric treatment in the next few years. But the psychedelic-like dissociative ketamine is already there. Join us on January 20, 2021 for a series of talks about the current and possible future roles of ketamine treatment in psychiatry. Read more
Psykedeelinäkymiä 2019: MDMA-assisted psychotherapy – why? - On Saturday, October 5th, 2019, the Finnish Association for Psychedelic Research will organize a full-day seminar titled “MDMA-assisted psychotherapy – why?” in Ruoholahti, Helsinki. The event is aimed at professionals and students of medicine, psychology, psychotherapy and other relevant fields, but is open to anyone interested in the topic. Read more
Psykedeelinäkymiä 2019 – Psychedelics and integration - In May, the spotlight will again be on psychedelics, as the Finnish Association for Psychedelic Research (Psykedeelitutkimusyhdistys ry, Psyty) organizes a lecture event in Helsinki on the theme of integrating psychedelic experiences. Psychologist and psychotherapist Marc Aixalà from Barcelona and psychologist Riikka Ajantaival will speak at the event. Read more
Psykedeelinäkymiä 2018 – MDMA and psilocybin assisted therapy - The Finnish Association for Psychedelic Research is organizing an all-day symposium on psychedelic research. The theme of the event is MDMA and psilocybin assisted therapy, featuring psychiatrist Ben Sessa, MD, from the UK, and Kim Kuypers, PhD, and Natasha Mason, MSc, from the Netherlands. Read more
Psykedeelinäkymiä 2017 – The therapeutic potential of psychedelics - The amount of scientific research on psychedelics has considerably increased during the last couple of decades. Substances like LSD, psilocybin, MDMA and ayahuasca are being studied as adjuncts to therapy for depression, addiction, post-traumatic stress disorder and anxiety related to terminal illness, and as tools for research on the neurobiology of consciousness. Two key experts… Read more